Some GLP-1 receptor agonists have also been approved for weight management in obese patients with a body mass index (BMI) greater than 30 kg/m or overweight patients with a BMI of 27 kg/m
Make sure the skin is clean before injecting and always use a new, straight needle for each dose
Motion Sickness|Travel Sickness the overactive bladder questionnaire (oab-q) caused you to adjust your travel plans so that you are always near a restroom
I think, as we get more experience with these drugs, we will realise that, for some people, different dosing, different doses, and different dosing schedules are appropriate
Ideal Candidates Microdosing GLP-1 medications may be appropriate for patients who fit certain profiles
Zepbound contains tirzepatide and activates GIP and GLP-1 pathways